Current Controlled Trials in Cardiovascular Medicine

[1]  N. Santanello,et al.  Randomised comparison of losartan vs. captopril on quality of life in elderly patients with symptomatic heart failure: The losartan heart failure ELITE quality of life substudy , 2004, Quality of Life Research.

[2]  北村 和之,et al.  Solas3.0 : for missing data analysis , 2001 .

[3]  J. Mckenney,et al.  Effect of niacin and atorvastatin on lipoprotein subclasses in patients with atherogenic dyslipidemia. , 2001, The American journal of cardiology.

[4]  A. Gotto,et al.  Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TEXCAPS): additional perspectives on tolerability of long-term treatment with lovastatin. , 2001, The American journal of cardiology.

[5]  W J Shih,et al.  Partial imputation approach to analysis of repeated measurements with dependent drop‐outs , 2001, Statistics in medicine.

[6]  J. Machac,et al.  Comparison of two calcium blockers on hemodynamics, left ventricular mass, and coronary vasodilatory in advanced hypertension. , 2001, American journal of hypertension.

[7]  A. Zanchetti,et al.  Comparison of candesartan versus enalapril in essential hypertension. Italian Candesartan Study Group. , 2001, American journal of hypertension.

[8]  P S Albert,et al.  Adjusting for drop-out in clinical trials with repeated measures: design and analysis issues. , 2001, Statistics in medicine.

[9]  K. Ferdinand,et al.  Efficacy and safety of omapatrilat with hydrochlorothiazide for the treatment of hypertension in subjects nonresponsive to hydrochlorothiazide alone. , 2000, American journal of hypertension.

[10]  David E. Booth,et al.  Analysis of Incomplete Multivariate Data , 2000, Technometrics.

[11]  Yang C. Yuan,et al.  Multiple Imputation for Missing Data: Concepts and New Development , 2000 .

[12]  J. Lachin.  Worst-rank score analysis with informatively missing observations in clinical trials. , 1999, Controlled clinical trials.

[13]  D. Schoenfeld,et al.  Combining mortality and longitudinal measures in clinical trials. , 1999, Statistics in medicine.

[14]  Coen A. Bernaards,et al.  SOLAS for Missing Data Analysis by Statistical Solutions Ltd.: Software Review , 1999 .

[15]  J F Troendle.  Testing for treatment differences with dropouts present in clinical trials--a composite approach. , 1998, Statistics in medicine.

[16]  W J Shih,et al.  Testing for treatment differences with dropouts present in clinical trials--a composite approach. , 1997, Statistics in medicine.

[17]  N M Laird,et al.  Model-based approaches to analysing incomplete longitudinal and failure time data. , 1997, Statistics in medicine.

[18]  J. Lubsen,et al.  Effect of pimobendan on exercise capacity in patients with heart failure: main results from the Pimobendan in Congestive Heart Failure (PICO) trial. , 1996, Heart.

[19]  Roderick J. A. Little,et al.  Modeling the Drop-Out Mechanism in Repeated-Measures Studies , 1995 .

[20]  M. Kenward,et al.  Informative Drop‐Out in Longitudinal Data Analysis , 1994 .

[21]  M. Kenward,et al.  Informative dropout in longitudinal data analysis (with discussion) , 1994 .

[22]  M D Schluchter,et al.  Methods for the analysis of informatively censored longitudinal data. , 1992, Statistics in medicine.

[23]  J. Lewis.  Correcting for the bias caused by dropouts in hypertension trials. , 1989, Statistics in medicine.

[24]  J. G. Findlay,et al.  Correcting for the bias caused by drop-outs in hypertension trials. , 1988, Statistics in medicine.

[25]  Raymond J. Carroll,et al.  Estimation and comparison of changes in the presence of informative right censoring by modeling the censoring process , 1988 .

[26]  J. Wittes,et al.  Analysis of data from clinical trials. , 1983, Annals of internal medicine.

[27]  D. Holt,et al.  Planning and Analysis of Observational Studies. , 1983 .

[28]  A L Gould,et al.  A new approach to the analysis of clinical drug trials with withdrawals. , 1980, Biometrics.

[29]  P. Armitage.  The Analysis of Data from Clinical Trials , 1979 .